Abstract 4365640: Machine Learning–Based Prediction of Right Heart Failure After LVAD Implantation with Visualization of Individual Risk Factors

T Takaaki Samura (Tokyo Medical and Dental University, Tokyo, Japan) H Hideki Masaki (Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo) D Daisuke Yoshioka (Department of Integrative Physiology, Graduate School of Medicine, The University of Osaka) K Kohei Tonai (National Cerebral and Cardiovascular Center, Osaka, Japan) Y Yasumasa Tsukamoto (National Cerebral and Cardiovascular Center, Osaka, Japan) S Satsuki Fukushima H Hiromitsu Nakauchi S Shigeru Miyagawa

Abstract

Introduction: Right ventricular failure (RVF) is a major adverse event following left ventricular assist device (LVAD) implantation. The complex mechanisms involved make it challenging to accurately predict RVF. Although supervised machine learning is useful for predicting complex outcomes, it is often difficult to identify specific factors that increase a patient's risk. This study aimed to assess the risk of RVF in individual patients and identify their unique risk factors using supervised machine learning. Methods: Between June 2010 and January 2024, 482 consecutive patients underwent continuous-flow LVAD implantation at Osaka University Hospital or the National Cerebral and Cardiovascular Center. Of them, 326 who underwent preoperative right heart catheterization and echocardiography were included in the analysis. Important features for predicting the risk of RVF were selected using the χ2 or Mann-Whitney U test, the Gini index in a random forest algorithm, and a literature review. The optimal classification algorithm for this analysis was selected from among the random forest, eXtreme Gradient Boosting, support vector machine, logistic regression, and ensemble learning algorithms by comparison of the area under the curve, accuracy, F1 score, and sensitivity through five-fold cross-validation of the test data. The SHapley Additive exPlanations (SHAP) value was used to assess the individual risk factors for RVF. Results: Thirteen important features (sex, age, non-ischemic cardiomyopathy, body surface area, aspartate aminotransferase level, blood urea nitrogen level, left ventricular end-diastolic dimension, left ventricular ejection fraction, right ventricular stroke work index, central venous pressure, pulmonary capillary wedge pressure, pulmonary pulsatility index, and Interagency Registry for Mechanically Assisted Circulatory Support profile) were selected. Ensemble learning was the most reliable classification algorithm. The area under the curve, accuracy, F1 score, and sensitivity were 0.87, 0.89, 0.77, and 0.80, respectively. The SHAP analysis revealed that impaired right ventricular function assessed by right heart catheterization, poor preoperative condition, and a good ejection fraction were associated with an increased risk in most cases. Conclusions: Supervised machine learning enables the accurate prediction of RVF after LVAD implantation, while SHAP values visualize individual risk factors and may optimize preoperative conditions.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (8)

T

Takaaki Samura

Tokyo Medical and Dental University, Tokyo, Japan

H

Hideki Masaki

Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo

D

Daisuke Yoshioka

Department of Integrative Physiology, Graduate School of Medicine, The University of Osaka

K

Kohei Tonai

National Cerebral and Cardiovascular Center, Osaka, Japan

Y

Yasumasa Tsukamoto

National Cerebral and Cardiovascular Center, Osaka, Japan

S

Satsuki Fukushima

H

Hiromitsu Nakauchi

S

Shigeru Miyagawa